CollPlant Biotechnologies (CLGN) vs HeartSciences (HSCS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
HeartSciences is the larger company by market cap ($14.7 million vs $7.5 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLGN | HSCS |
|---|---|---|
| Share price | $3.97 | $3.04 |
| Market cap | $7.51M | $14.73M |
| 1-day change | +14.74% | -12.89% |
| YTD return | — | -1.62% |
| 1-year return | — | -18.28% |
| EPS (TTM) | $-9.33 | $-3.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.80 | $5.25 |
| 52-week low | $2.64 | $1.63 |
| Distance from 52-week high | -85.19% | -42.10% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +294.74% |
| Average volume | 351.98K | 154.08K |
| Shares outstanding | 1.89M | 4.84M |
| Employees | 39 | 14 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CollPlant Biotechnologies
CLGN stock →CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology.
Healthcare · Biotechnology · 39 employees
About HeartSciences
HSCS stock →HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform.
Healthcare · Medical Devices · 14 employees
CLGN vs HSCS FAQ
Which is bigger, CollPlant Biotechnologies or HeartSciences?
HeartSciences (HSCS) is larger, with a market capitalization of $14.73M compared with $7.51M for CollPlant Biotechnologies (CLGN).
Are CollPlant Biotechnologies and HeartSciences in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for CollPlant Biotechnologies and Medical Devices for HeartSciences.